| LP247823-0 | Bacterial identification and susceptibility panel | COMPONENT | 1 |
| LP247825-5 | Mycobacterium avium and Mycobacterium intracellulare | COMPONENT | |
| LP247827-1 | Mycoplasma hyopneumoniae P146 gene sequence and phylogenetic analysis | COMPONENT | 1 |
| LP247830-5 | Cancer specimen | SYSTEM | 64 |
| LP247831-3 | Excised length | COMPONENT | 1 |
| LP247832-1 | Adjacent structure invaded by tumor | COMPONENT | 3 |
| LP247833-9 | Organ tumor is adherent to | COMPONENT | 1 |
| LP247834-7 | Distance of carcinoma from closest surgical margin when all margins are uninvolved | COMPONENT | 1 |
| LP247835-4 | Distance of carcinoma from closest mucosal margin when all mucosal margins are uninvolved | COMPONENT | 1 |
| LP247836-2 | Closest surgical margin when all margins are uninvolved | COMPONENT | 1 |
| LP247837-0 | Radial position of closest uninvolved mucosal margin | COMPONENT | 1 |
| LP247838-8 | Radial position of closest mucosal margin involved by invasive carcinoma | COMPONENT | 1 |
| LP247839-6 | Surgical margin tumor involvement.mesenteric | COMPONENT | 1 |
| LP247840-4 | Polyp in which invasive carcinoma arose | COMPONENT | 1 |
| LP247841-2 | Signet ring cells | COMPONENT | |
| LP247842-0 | Mucinous fraction | COMPONENT | 1 |
| LP247843-8 | Promoter methylation testing method | COMPONENT | 1 |
| LP247844-6 | Tumor budding | COMPONENT | 1 |
| LP247845-3 | Tumor buds | COMPONENT | 1 |
| LP247846-1 | Surgical margin tumor involvement | COMPONENT | 1 |
| LP247851-1 | Breast cancer specimen | SYSTEM | 42 |
| LP247860-2 | Influenza virus D | COMPONENT | |
| LP247862-8 | Expected delivery location | COMPONENT | 1 |
| LP247863-6 | Reason vaccine not received | COMPONENT | 1 |
| LP247864-4 | Vaccinated based on recommended guidelines | COMPONENT | 1 |
| LP247865-1 | Autopsy result | COMPONENT | 1 |
| LP247866-9 | Year previously tested for rubella virus immunity | COMPONENT | 1 |
| LP247867-7 | Previous rubella virus test result | COMPONENT | 1 |
| LP247868-5 | Documentation of previous rubella immunity testing | COMPONENT | 1 |
| LP247869-3 | Prior condition onset year | COMPONENT | 1 |
| LP247870-1 | Previous rubella disease was serologically confirmed | COMPONENT | 1 |
| LP247871-9 | Rubella diagnosis | COMPONENT | |
| LP247872-7 | Age at time of immunity testing | COMPONENT | 1 |
| LP247873-5 | Age and setting of exposure to illness verified | COMPONENT | 1 |
| LP247874-3 | Received vaccination for illness of interest | COMPONENT | 1 |
| LP247875-0 | Number of deliveries in the U.S. | COMPONENT | 1 |
| LP247876-8 | Year of previous delivery in the U.S. | COMPONENT | 1 |
| LP247877-6 | Has had previous deliveries in the U.S. | COMPONENT | 1 |
| LP247879-2 | Directly exposed to a confirmed case | COMPONENT | 1 |
| LP247880-0 | Traveled outside the U.S. during first trimester of pregnancy | COMPONENT | 1 |
| LP247881-8 | Distance of carcinoma from anterior margin | COMPONENT | 1 |
| LP247882-6 | Distance of carcinoma from posterior margin | COMPONENT | 1 |
| LP247883-4 | Distance of carcinoma from superior margin | COMPONENT | 1 |
| LP247884-2 | Distance of carcinoma from inferior margin | COMPONENT | 1 |
| LP247885-9 | Distance of carcinoma from lateral margin | COMPONENT | 1 |
| LP247886-7 | Distance of carcinoma from medial margin | COMPONENT | 1 |
| LP247888-3 | Growth pattern of DCIS | COMPONENT | 1 |
| LP247889-1 | Lymph node site of origin | COMPONENT | 1 |
| LP247891-7 | Cells.estrogen receptor | COMPONENT | |
| LP247892-5 | Cells.progesterone receptor | COMPONENT | |